Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
70°
Partly Cloudy
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
Photos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Best of 2023
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Vericel Corporation
Vericel Announces FDA Approval of NexoBrid for the Treatment of Pediatric Patients with Severe Thermal Burns
August 15, 2024
From
Vericel Corporation
Via
GlobeNewswire
Tickers
VCEL
Vericel to Present at the Canaccord Genuity Growth Conference on Wednesday, August 14, 2024
August 07, 2024
From
Vericel Corporation
Via
GlobeNewswire
Tickers
VCEL
Vericel Reports Second Quarter 2024 Financial Results
August 01, 2024
From
Vericel Corporation
Via
GlobeNewswire
Tickers
VCEL
Vericel Announces Appointment of Karen Mahoney as Chief Human Resources Officer
July 22, 2024
From
Vericel Corporation
Via
GlobeNewswire
Tickers
VCEL
Vericel to Report Second-Quarter 2024 Financial Results on August 1, 2024
July 18, 2024
From
Vericel Corporation
Via
GlobeNewswire
Tickers
VCEL
Vericel to Present at the Truist Securities MedTech Conference on Tuesday, June 18, 2024
June 11, 2024
From
Vericel Corporation
Via
GlobeNewswire
Tickers
VCEL
Vericel to Present at the Leerink Partners Healthcare Crossroads Conference on Wednesday, May 29, 2024
May 22, 2024
From
Vericel Corporation
Via
GlobeNewswire
Tickers
VCEL
Vericel Reports First Quarter 2024 Financial Results and Raises Full-Year 2024 Financial Guidance
May 08, 2024
From
Vericel Corporation
Via
GlobeNewswire
Tickers
VCEL
Vericel to Report First-Quarter 2024 Financial Results on May 8, 2024
April 24, 2024
From
Vericel Corporation
Via
GlobeNewswire
Tickers
VCEL
Vericel Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Full-Year 2024 Financial Guidance
February 29, 2024
From
Vericel Corporation
Via
GlobeNewswire
Tickers
VCEL
Vericel to Present at the TD Cowen 44th Annual Health Care Conference on Tuesday, March 5, 2024
February 27, 2024
From
Vericel Corporation
Via
GlobeNewswire
Tickers
VCEL
Vericel to Report Fourth-Quarter and Full-Year 2023 Financial Results on February 29, 2024
February 15, 2024
From
Vericel Corporation
Via
GlobeNewswire
Tickers
VCEL
Vericel to Present at the Canaccord Genuity Musculoskeletal Conference on Monday, February 12, 2024
February 05, 2024
From
Vericel Corporation
Via
GlobeNewswire
Tickers
VCEL
Vericel Announces Preliminary Full-Year and Fourth Quarter 2023 Financial Results
January 09, 2024
From
Vericel Corporation
Via
GlobeNewswire
Tickers
VCEL
Vericel to Present at the 42nd Annual J.P. Morgan Healthcare Conference on Wednesday, January 10, 2024
January 03, 2024
From
Vericel Corporation
Via
GlobeNewswire
Tickers
VCEL
Vericel Reports Third Quarter 2023 Financial Results and Raises Full-Year 2023 Financial Guidance
November 08, 2023
From
Vericel Corporation
Via
GlobeNewswire
Tickers
VCEL
Vericel to Present at the Stephens Annual Investment Conference
November 07, 2023
From
Vericel Corporation
Via
GlobeNewswire
Tickers
VCEL
Vericel to Report Third-Quarter 2023 Financial Results on November 8, 2023
October 25, 2023
From
Vericel Corporation
Via
GlobeNewswire
Tickers
VCEL
Vericel Announces Publication of Positive Results from Phase 3 Debride and Protect (DETECT) Study of Thermal Burn Patients Treated with NexoBrid
September 28, 2023
From
Vericel Corporation
Via
GlobeNewswire
Tickers
VCEL
Vericel Announces U.S. Commercial Availability of NexoBrid® (anacaulase-bcdb) for the Treatment of Severe Thermal Burns in Adults
September 20, 2023
From
Vericel Corporation
Via
GlobeNewswire
Tickers
VCEL
Vericel to Present at the Morgan Stanley Global Healthcare Conference
September 06, 2023
From
Vericel Corporation
Via
GlobeNewswire
Tickers
VCEL
Vericel Reports Second Quarter 2023 Financial Results and Raises Full-Year 2023 Financial Guidance
August 02, 2023
From
Vericel Corporation
Via
GlobeNewswire
Tickers
VCEL
Vericel to Report Second-Quarter 2023 Financial Results on August 2, 2023
July 20, 2023
From
Vericel Corporation
Via
GlobeNewswire
Tickers
VCEL
Vericel Reports First Quarter 2023 Financial Results and Raises Full-Year 2023 Financial Guidance
May 10, 2023
From
Vericel Corporation
Via
GlobeNewswire
Tickers
VCEL
Vericel to Report First-Quarter 2023 Financial Results on May 10, 2023
April 26, 2023
From
Vericel Corporation
Via
GlobeNewswire
Tickers
VCEL
Vericel to Present at the Canaccord Genuity Musculoskeletal Conference on Tuesday, March 7, 2023
February 28, 2023
From
Vericel Corporation
Via
GlobeNewswire
Tickers
VCEL
Vericel Reports Fourth Quarter and Full-Year 2022 Financial Results and Provides Full-Year 2023 Financial Guidance
February 23, 2023
From
Vericel Corporation
Via
GlobeNewswire
Tickers
VCEL
Vericel to Report Fourth-Quarter 2022 Financial Results on February 23, 2023
February 09, 2023
From
Vericel Corporation
Via
GlobeNewswire
Tickers
VCEL
Vericel Announces Preliminary Fourth-Quarter and Full-Year 2022 Financial Results and Accelerated Launch Timeline for MACI Arthroscopic Program
January 10, 2023
From
Vericel Corporation
Via
GlobeNewswire
Tickers
VCEL
Vericel to Present at the 41st Annual J.P. Morgan Healthcare Conference on Wednesday, January 11, 2023
January 04, 2023
From
Vericel Corporation
Via
GlobeNewswire
Tickers
VCEL
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.